Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.59 |
| ▸ | GAA | P10253 | 2/20 | 0.59 |
| ▸ | APP | P05067 | 1/20 | 0.59 |
| ▸ | HCAR3 | P49019 | 1/20 | 0.59 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.59 |
| ▸ | HTT | P42858 | 1/20 | 0.57 |
| ▸ | F7 | P08709 | 1/20 | 0.57 |
| ▸ | F3 | P13726 | 1/20 | 0.57 |
| ▸ | SARM1 | Q6SZW1 | 1/20 | 0.57 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.57 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.57 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.57 |
| ▸ | SIRT3 | Q9NTG7 | 1/20 | 0.57 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.57 |
| ▸ | SIRT4 | Q9Y6E7 | 1/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.56 |
| ▸ | TSHR | P16473 | 2/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.56 |
| ▸ | USP2 | O75604 | 1/20 | 0.56 |
| ▸ | TP53 | P04637 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31699264 | 1.00 | ALDH1A1 (0.59) | ALDH1A1GAAAPPHCAR3HCAR2 | |
| Hydrochloric Acid SCHEMBL7835171 | 0.98 | ALDH1A1 (0.57) | ALDH1A1GAAAPPHCAR3HCAR2 | |
| Bromide SCHEMBL6550191 | 0.98 | ALDH1A1 (0.57) | ALDH1A1GAAAPPHCAR3HCAR2 | |
| SCHEMBL29089330 | 0.98 | ALDH1A1 (0.57) | ALDH1A1GAAAPPHCAR3HCAR2 | |
| Iodide SCHEMBL27448062 | 0.98 | ALDH1A1 (0.57) | ALDH1A1GAAAPPHCAR3HCAR2 | |
| Hydrogen Peroxide SCHEMBL28248196 | 0.98 | ALDH1A1 (0.62) | ALDH1A1GAAAPPHCAR3HCAR2 | |
| Nicotinyl Methylamide SCHEMBL21826684 | 0.88 | HDAC1 (0.56) | ALDH1A1GAAAPPHCAR3HCAR2 | |
| SCHEMBL93651 | 0.86 | ALDH1A1 (0.57) | ALDH1A1GAAAPPHCAR3HCAR2 | |
| SCHEMBL4002015 | 0.85 | F7 (0.58) | ALDH1A1GAAAPPHCAR3HCAR2 | |
| SCHEMBL12562403 | 0.85 | ALDH1A1 (0.55) | ALDH1A1GAAAPPHCAR3HCAR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 704 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4687829-A1 | COMPOSITION FOR CARING FOR KERATIN MATERIALS | L'OREAL (FR) | 2026-02-11 | — | — | EP | claimed |
| US-20250381116-A1 | SOLUBILIZATION OF THIOPYRIDINONE COMPOUND AND COMPOSITION COMPRISING SAME | OREAL (FR) | 2025-12-18 | — | — | US | claimed |
| US-12486260-B2 | Indazolyl-isoxazole derivatives for the treatment of diseases such as cancer | MERCK PATENT GMBH (DE) | 2025-12-02 | — | — | US | claimed |
| CN-120081975-A | Preparation method of corrosion and scale inhibition integrated thickener for cationic acidizing and fracturing | 爱森（中国）絮凝剂有限公司 | 2025-06-03 | — | — | CN | claimed |
| WO-2025091239-A1 | COMPOSITION IN THE FORM OF OIL-IN-WATER EMULSION | L'OREAL (FR) | 2025-05-08 | — | — | WO | claimed |
| WO-2025091220-A2 | COMPOSITION IN THE FORM OF OIL-IN-WATER EMULSION | L'OREAL (FR) | 2025-05-08 | — | — | WO | claimed |
| EP-4543408-A1 | SOLUBILIZATION OF THIOPYRIDINONE COMPOUND AND COMPOSITION COMPRISING SAME | L'OREAL (FR) | 2025-04-30 | — | — | EP | claimed |
| CN-115427409-B | Pyrimidine-4 (3H) -one derivatives as TRPV4 antagonists | 拉夸里亚创药株式会社 | 2025-02-25 | — | — | CN | claimed |
| WO-2024197798-A1 | COMPOSITION FOR CARING FOR KERATIN MATERIALS | L'OREAL (FR) | 2024-10-03 | — | — | WO | claimed |
| CN-117736085-A | Catalytic hydrogenation preparation method of 2-methyl succinic acid | 河北旭阳能源有限公司 | 2024-03-22 | — | — | CN | claimed |
| WO-1998033786-A1 | ACCELERATED CATALYSIS OF OLEFINIC EPOXIDATIONS | THE SCRIPPS RESEARCH INSTITUTE (US) | 1998-08-06 | — | — | WO | claimed |
| CN-1164174-A | Antidote composition and method of using the same | NITROKEMIA RT (HU) | 1997-11-05 | — | — | CN | claimed |
| US-5474971-A | High speed disintegration | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1995-12-12 | — | — | US | claimed |
| CN-1077842-A | Reversible agricultural gel and paste composition | DU PONT (US) | 1993-11-03 | — | — | CN | claimed |
| CN-1077838-A | The sweep-out method of spray tank | DU PONT (US) | 1993-11-03 | — | — | CN | claimed |
| WO-1993016596-A1 | METHOD FOR SPRAY TANK CLEANOUT | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1993-09-02 | — | — | WO | claimed |
| CN-1074083-A | The tablet formulation that contains internal desiccant | DU PONT (US) | 1993-07-14 | — | — | CN | claimed |
| CN-1065181-A | WATER-DISPERSIBLE GRANULES AGRICULTURAL COMPOSITIONS MADE BY HEAT EXTRUSION | DU PONT (US) | 1992-10-14 | — | — | CN | claimed |
| CN-87101735-A | HERBICIDAL PYRIDINE SULFONAMIDES | — | 1987-09-16 | — | — | CN | claimed |
| US-4018932-A | 2,3,5,6-TETRAHYDRO-IMIDAZO (2,1-6) THIAZOLE | AMERICAN CYANAMID COMPANY (US) | 1977-04-19 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12486260-B2 | Indazolyl-isoxazole derivatives for the treatment of diseases such as cancer | KIT, TNNI3K, CILK1 | ALDH1A1 421/4885GAA 988/4885APP 4731/4885 |
| US-20250381116-A1 | SOLUBILIZATION OF THIOPYRIDINONE COMPOUND AND COMPOSITION COMPRISING SAME | TBCB, CCNB3, CYP24A1 | ALDH1A1 2124/4885GAA 4523/4885APP 694/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.